Avoid common mistakes on your manuscript.
Correction to: Seminars in Immunopathology (2021) 43:789-797
References
Tatapudi VS, Montgomery RA (2019) Therapeutic modulation of the complement system in kidney transplantation: clinical indications and emerging drug leads. Front Immunol 10:2306
C1-Inhibitor (INH) for Refractory Antibody Mediated Renal Allograft Rejection. https://ClinicalTrials.gov/show/NCT02936479
Amyndas. https://www.amyndas.com/researchfocus. Accessed 20/09/21
Hillmen P, Szer J, Weitz I, Roth A, Hochsmann B, Panse J, Usuki K, Griffin M, Kiladjian JJ, de Castro C, Nishimori H, Tan L, Hamdani M, Deschatelets P, Francois C, Grossi F, Ajayi T, Risitano A, de la Tour RP (2021) Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. N Engl J Med 384:1028–1037
Jaffe GJ, Sahni J, Fauser S, Geary RS, Schneider E, McCaleb M (2020) Development of IONIS-FB-LRx to treat geographic atrophy associated with AMD. Investig Ophthalmol Vis Sci 61:4305
Risitano AM, Kulasekararaj AG, Lee JW, Maciejewski JP, Notaro R, Brodsky R, Huang M, Geffner M, Browett P (2020) Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria. Haematologica. Online ahead of print
Polycarpou A, Howard M, Farrar CA, Greenlaw R, Fanelli G, Wallis R, Klavinskis LS, Sacks S (2020) Rationale for targeting complement in COVID-19. EMBO Mol Med 12:e12642
Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S, Paranjpe I, Somani S, Richter F, Miotto R, Lala A, Kia A, Timsina P, Li L, Freeman R, Chen R, Narula J, Just AC, Horowitz C, Fayad Z, Cordon-Cardo C, Schadt E, Levin MA, Reich DL, Fuster V, Murphy B, He JC, Charney AW, Bottinger EP, Glicksberg BS, Coca SG, Nadkarni GN, Mount Sinai CIC (2021) AKI in hospitalized patients with COVID-19. J Am Soc Nephrol 32:151–160
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Howard, M.C., Nauser, C.L., Farrar, C.A. et al. Correction to: Complement in ischaemia–reperfusion injury and transplantation. Semin Immunopathol 44, 391 (2022). https://doi.org/10.1007/s00281-022-00924-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00281-022-00924-w